AS² Bio is providing a “bridge” from Proof of Concept (POC) to First in Human (FIH) for Angelman syndrome programs.

​

Each AS program becomes part of a structured and supportive ecosystem with the purpose of leveraging managerial talent and resources across all the AS programs, providing:

​

• Experts with skills typical of a biotech (Nonclinical and Clinical Operations, Regulatory, Program and Trial development…)
   

• Centralized program development, business and support services
   

• Aggregation of knowledge bank, set of SOPs, funding efforts...
   

• Established network and relationships with the ecosystem (universities, pharma, CROs, CDMOs…)